Millennium Management
ORIC icon

Millennium Management’s Oric Pharmaceuticals ORIC Stock Holding History

Millennium Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$431K Sell
34,012
-63,420
-65% -$720K ﹤0.01% 4842
2025
Q4 		$797K Sell
97,432
-43,001
-31% -$495K ﹤0.01% 4644
2025
Q3 		$1.69M Sell
140,433
-210,102
-60% -$2.21M ﹤0.01% 4207
2025
Q2 		$3.56M Buy
350,535
+296,552
+549% +$1.99M ﹤0.01% 3331
2025
Q1 		$301K Buy
53,983
+26,349
+95% +$230K ﹤0.01% 5101
2024
Q4 		$223K Sell
27,634
-265,889
-91% -$2.44M ﹤0.01% 5245
2024
Q3 		$3.01M Sell
293,523
-488,776
-62% -$4.83M ﹤0.01% 3313
2024
Q2 		$5.53M Buy
782,299
+585,447
+297% +$5.24M ﹤0.01% 2639
2024
Q1 		$2.71M Buy
+196,852
New +$2.34M ﹤0.01% 3468
2023
Q4 		– Sell
-1,163,760
Closed -$7.04M – 6404
2023
Q3 		$7.04M Buy
1,163,760
+7,650
+0.7% +$62.7K ﹤0.01% 2387
2023
Q2 		$8.97M Sell
1,156,110
-1,111,532
-49% -$6.31M ﹤0.01% 2128
2023
Q1 		$12.9M Buy
2,267,642
+383,664
+20% +$2M 0.01% 1714
2022
Q4 		$11.1M Buy
1,883,978
+355,370
+23% +$1.2M 0.01% 2024
2022
Q3 		$4.89M Buy
1,528,608
+86,631
+6% +$347K ﹤0.01% 2905
2022
Q2 		$6.46M Buy
1,441,977
+1,064,486
+282% +$4.25M ﹤0.01% 2530
2022
Q1 		$2.02M Buy
+377,491
New +$3.4M ﹤0.01% 3874
2021
Q3 		– Sell
-231,853
Closed -$4.1M – 7112
2021
Q2 		$4.1M Buy
231,853
+108,396
+88% +$2.38M ﹤0.01% 3026
2021
Q1 		$3.02M Buy
123,457
+21,595
+21% +$682K ﹤0.01% 3127
2020
Q4 		$3.45M Buy
101,862
+77,372
+316% +$2.22M ﹤0.01% 2795
2020
Q3 		$612 Buy
+24,490
New +$583K ﹤0.01% 3467

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Millennium Management's ORIC Position: Q1 2026 in Review

Millennium Management reduced its Oric Pharmaceuticals (ORIC) stake by 65% in Q1 2026, selling an estimated $720K and leaving 34,012 shares worth $431K. The position accounts for ﹤0.01% of the portfolio, ranked #4842.

Millennium Management first reported a position in ORIC in Q3 2020 and has held it in 20 quarters since. The position peaked at $12.9M in Q1 2023. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Millennium Management held 34,012 shares of Oric Pharmaceuticals worth $431K as of Q1 2026.
  • Millennium Management sold 63,420 Oric Pharmaceuticals shares in Q1 2026, an estimated $720K.
  • Oric Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4842 holding.
  • Millennium Management first reported a position in Oric Pharmaceuticals in Q3 2020 and has held it in 20 quarters since.
  • Millennium Management's Oric Pharmaceuticals position peaked at $12.9M in Q1 2023.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.